Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius Medical to EUR 34 from EUR 33 and keeps an Underweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FMS:
- A New Cause for Concern: Fresenius Medical Care Adds a New International Operations Risk
- Fresenius Medical Care delivers on commitments in a year of fundamental transformation
- Fresenius Medical price target raised to EUR 33 from EUR 28 at JPMorgan
- Fresenius Medical reinstated with an Underperform at BofA
- Fresenius Medical downgraded to Underweight from Equal Weight at Morgan Stanley
